Our global membership includes infectious disease physicians, microbiologists, pharmacists, GPs, nurses, and researchers – many of whom are on the “front line” of this unprecedented public health emergency. As well as acknowledging their hard work and endeavour, we are working behind-the-scenes to assess what support our healthcare professionals and scientists need from their learned societies, both now and in the near-future.
Our immediate offering is launch of COVID-19 funding call to support researchers in better understanding and addressing COVID-19 outbreaks. We also remain committed to providing free membership to professionals across the world, while the publisher of our Journals – JAC and JAC-AMR, Oxford University Press, has made COVID-19 related content from online resources and leading journals freely accessible to assist researchers, medical professionals, policymakers, and others who are working to address this health crisis.
Longer term it’s clear that the approach to drug-resistant infection and pandemic preparedness should be combined. Consequently, we are weighing up what help we can provide through our online education programmes, initiatives that relieve burden on health services by taking care closer to home – such as the UK Outpatient Parenteral Antimicrobial Therapy (OPAT) initiative (www.e-opat.com), our journals, and the way we inform and influence.
Lastly, and under our mantra ‘better together than alone’, if other Societies, organisations, or individuals, would like to join forces to inform how we share expertise and practical resources, we would be pleased to hear from them.
After all, the very point of a Society is to protect and promote through mutual support.
CEO of the British Society for Antimicrobial Chemotherapy